Global Biosimilars of Monoclonal Antibody Sales Market Report 2017

Name: Global Biosimilars of Monoclonal Antibody Sales Market Report 2017
Brand: QYResearch
SKU: GAFDBCC6826EN
Price: 4000 USD
Availability: InStock

August 2017 | 114 pages | ID: GAFDBCC6826EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the global Biosimilars of Monoclonal Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biosimilars of Monoclonal Antibody for these regions, from 2012 to 2022 (forecast), covering

United States
China
Europe
Japan
Southeast Asia
India

Global Biosimilars of Monoclonal Antibody market competition by top manufacturers/players, with Biosimilars of Monoclonal Antibody sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
GSK
BMS

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

Type I
Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilars of Monoclonal Antibody for each application, including

Application 1
Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Biosimilars of Monoclonal Antibody Sales Market Report 2017

1 BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilars of Monoclonal Antibody
1.2 Classification of Biosimilars of Monoclonal Antibody by Product Category
  1.2.1 Global Biosimilars of Monoclonal Antibody Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Biosimilars of Monoclonal Antibody Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Type I
  1.2.4 Type II
1.3 Global Biosimilars of Monoclonal Antibody Market by Application/End Users
  1.3.1 Global Biosimilars of Monoclonal Antibody Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.1 Application
  1.3.2 Application
1.4 Global Biosimilars of Monoclonal Antibody Market by Region
  1.4.1 Global Biosimilars of Monoclonal Antibody Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
  1.4.3 China Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
  1.4.4 Europe Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
  1.4.5 Japan Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
  1.4.7 India Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biosimilars of Monoclonal Antibody (2012-2022)
  1.5.1 Global Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2022)
  1.5.2 Global Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2022)

2 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Biosimilars of Monoclonal Antibody Market Competition by Players/Suppliers
  2.1.1 Global Biosimilars of Monoclonal Antibody Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Biosimilars of Monoclonal Antibody Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Biosimilars of Monoclonal Antibody (Volume and Value) by Type
  2.2.1 Global Biosimilars of Monoclonal Antibody Sales and Market Share by Type (2012-2017)
  2.2.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
2.3 Global Biosimilars of Monoclonal Antibody (Volume and Value) by Region
  2.3.1 Global Biosimilars of Monoclonal Antibody Sales and Market Share by Region (2012-2017)
  2.3.2 Global Biosimilars of Monoclonal Antibody Revenue and Market Share by Region (2012-2017)
2.4 Global Biosimilars of Monoclonal Antibody (Volume) by Application

3 UNITED STATES BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

3.1 United States Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  3.1.1 United States Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  3.1.2 United States Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  3.1.3 United States Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
3.2 United States Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
3.3 United States Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
3.4 United States Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

4 CHINA BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

4.1 China Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  4.1.1 China Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  4.1.2 China Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  4.1.3 China Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
4.2 China Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
4.3 China Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
4.4 China Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

5 EUROPE BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  5.1.1 Europe Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  5.1.2 Europe Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
5.2 Europe Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
5.3 Europe Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
5.4 Europe Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

6 JAPAN BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  6.1.1 Japan Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  6.1.2 Japan Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
6.2 Japan Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
6.3 Japan Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
6.4 Japan Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

7 SOUTHEAST ASIA BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  7.1.1 Southeast Asia Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
7.2 Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
7.3 Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
7.4 Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

8 INDIA BIOSIMILARS OF MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 India Biosimilars of Monoclonal Antibody Sales and Value (2012-2017)
  8.1.1 India Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2017)
  8.1.2 India Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 India Biosimilars of Monoclonal Antibody Sales Price Trend (2012-2017)
8.2 India Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Players
8.3 India Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Type
8.4 India Biosimilars of Monoclonal Antibody Sales Volume and Market Share by Application

9 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Pfizer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Roche
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Roche Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Eli Lilly
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Eli Lilly Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Bayer
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Bayer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Amgen
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Amgen Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Sanofi-Aventis
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Novo Nordisk
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novo Nordisk Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Merck
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Merck Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 GSK
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 GSK Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 BMS

10 BIOSIMILARS OF MONOCLONAL ANTIBODY MAUFACTURING COST ANALYSIS

10.1 Biosimilars of Monoclonal Antibody Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody
10.3 Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Biosimilars of Monoclonal Antibody Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL BIOSIMILARS OF MONOCLONAL ANTIBODY MARKET FORECAST (2017-2022)

14.1 Global Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Biosimilars of Monoclonal Antibody Price and Trend Forecast (2017-2022)
14.2 Global Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Biosimilars of Monoclonal Antibody Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biosimilars of Monoclonal Antibody Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Biosimilars of Monoclonal Antibody Sales Forecast by Type (2017-2022)
  14.3.2 Global Biosimilars of Monoclonal Antibody Revenue Forecast by Type (2017-2022)
  14.3.3 Global Biosimilars of Monoclonal Antibody Price Forecast by Type (2017-2022)
14.4 Global Biosimilars of Monoclonal Antibody Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilars of Monoclonal Antibody
Figure Global Biosimilars of Monoclonal Antibody Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure Global Biosimilars of Monoclonal Antibody Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Biosimilars of Monoclonal Antibody by Application in 2016
Figure Application 1 Examples
Table Key Downstream Customer in Application
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure Global Biosimilars of Monoclonal Antibody Market Size (Million USD) by Regions (2012-2022)
Figure United States Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Biosimilars of Monoclonal Antibody Sales Volume (K Units) (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers
Figure 2017 Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers
Figure Global Biosimilars of Monoclonal Antibody Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Biosimilars of Monoclonal Antibody Revenue Share by Players
Table 2017 Global Biosimilars of Monoclonal Antibody Revenue Share by Players
Table Global Biosimilars of Monoclonal Antibody Sales (K Units) and Market Share by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Sales Growth Rate by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Sales Growth Rate by Region in 2016
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Revenue Growth Rate by Region in 2016
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Region (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share by Region in 2016
Table Global Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Biosimilars of Monoclonal Antibody Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Biosimilars of Monoclonal Antibody by Application (2012-2017)
Figure Global Biosimilars of Monoclonal Antibody Sales Market Share by Application (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Figure China Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure China Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table China Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table China Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table China Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure China Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Figure Europe Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table Europe Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table Europe Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure Europe Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Figure Japan Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table Japan Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table Japan Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure Japan Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Figure India Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2017)
Figure India Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biosimilars of Monoclonal Antibody Sales Price (USD/Unit) Trend (2012-2017)
Table India Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Players (2012-2017)
Table India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players (2012-2017)
Figure India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Players in 2016
Table India Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Type (2012-2017)
Table India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (2012-2017)
Figure India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type in 2016
Table India Biosimilars of Monoclonal Antibody Sales Volume (K Units) by Application (2012-2017)
Table India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application (2012-2017)
Figure India Biosimilars of Monoclonal Antibody Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Pfizer Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Pfizer Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Roche Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Roche Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Eli Lilly Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Bayer Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Bayer Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Amgen Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Amgen Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Novo Nordisk Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure Merck Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure Merck Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
Figure GSK Biosimilars of Monoclonal Antibody Sales Global Market Share (2012-2017
Figure GSK Biosimilars of Monoclonal Antibody Revenue Global Market Share (2012-2017)
Table BMS Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars of Monoclonal Antibody
Figure Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody
Figure Biosimilars of Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Players in 2016
Table Major Buyers of Biosimilars of Monoclonal Antibody
Table Distributors/Traders List
Figure Global Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Volume Market Share Forecast by Regions in 2022
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Regions in 2022
Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Biosimilars of Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Type (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Revenue Market Share Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Biosimilars of Monoclonal Antibody Sales (K Units) Forecast by Application (2017-2022)
Figure Global Biosimilars of Monoclonal Antibody Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Biosimilars of Monoclonal Antibody Sales Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports